Fluidigm Corporation


Fluidigm develops, manufactures, and markets proprietary integrated fluidic circuit (IFC) systems that significantly improve productivity for life science applications such as gene expression profiling, high-throughput SNP genotyping, singe cell/stem cell analysis, digital PCR, LOH and CNV analysis, mutation detection, and next gen sequencing. Fluidigm?? IFCs enable the simultaneous performance of thousands of sophisticated biochemical measurements in nanoliter volumes. These ??ntegrated circuits for biology??miniaturize and integrate liquid handling components on a single microfabricated device. Fluidigm?? IFC systems, consisting of instrumentation, software and single-use IFCs, increase throughput, decrease costs and enhance sensitivity compared to conventional laboratory systems. Fluidigm products have not been cleared or approved by the U.S. Food and Drug Administration for use as a diagnostic and are only available for research use.


Write a Review

Join 200,000 Scientists Online

Become a member for FREE for access to:

  • 250,000 full product and supplier listings
  • 10,000 user reviews and comments
  • Daily news and videos
  • 2,500 application notes and videos
  • 2,000 of the best jobs in Science

Don't miss out!

Join The Community Today